The flight, carrying celebrities like Katy Perry and Gayle King, reached a height of about 60 miles (96.6km) above Earth.

Qure (NASDAQ:QURE) shares added ~39% in the premarket on Thursday after the Dutch biotech announced that the FDA granted ...

Northern Scotland has one of the highest rates of Huntington's disease in the world, according to a new study. Huntington's ...

AMT-130 is administered through magnetic resonance imaging-guided, convection-enhanced stereotactic neurosurgical delivery into the striatum.

Breakthrough Therapy designation based on clinical evidence from Phase I/II trials showing meaningful slowing of disease progression ~~ ...

Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbe ...

The neurodegenerative disease slowly damages the brain, taking away the ability to walk, talk, eat, drink, make decisions and ...

New research shows that the adult brain can generate new neurons that integrate into key motor circuits, findings that may ...

Gene therapy developer uniQure shares soared 46% in premarket trading after its treatment for Huntington's disease received breakthrough therapy designation from the Food and Drug Administration.

Qure (QURE) announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy designation to AMT-130 for the treatment ...

New research shows that the adult brain can generate new neurons that integrate into key motor circuits. The findings ...